Clinical Trial Update: Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels [Phase 4]

View source ↗

Summary

Phase 4 study assessing the impact of dutasteride on intraprostatic DHT levels in men with benign prostatic hyperplasia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Phase 4 | Status: COMPLETED